0

Michelle Maalouf

  • Aging2.0, Head of Strategic Programs
  • San Francisco
  • Hospital & Health Care

About Me

Over the last 4 years, Michelle has played key roles in operations, programming and business development at Aging2.0. Before joining Aging2.0, Michelle performed research leading the development and application of an artificial nanopore used to inject into and biopsy from single human cells. Michelle is coauthor on multiple peer-reviewed papers and is an inventor on a U.S. and international patent. Michelle has a Masters in Biomolecular Engineering and Bioinformatics from The University of California, Santa Cruz (ChancellorAward recipient).

My blog posts

Aging2.0 Announces 2014-2015 Academy Cohort and Leaders Circle Members

Aging2.0 Announces: 2014-2015 Academy Cohort and Leaders Circle Members   Last week, Aging2.0 announced the second class of their startup program, the Aging2.0 Academy, and the launch of their new corporate partnership program, the Aging2.0 Leaders Circle. Additionally, the year-long Academy program officially commenced with a Kick-Off event in San Francisco on November 20th and 21st.
0

Brazil’s first mobile health ecosystem is presented at Aging2.0 São Paulo

Brazil’s first mobile health ecosystem is presented at Aging2.0 São Paulo Text and photos: Simone Jardim, edited by Alisa Rodriguez
0

How Evidence Based Research Can Help Get Your Start-Up Funded

How Evidence Based Research Can Help Get Your Start-Up Funded By: Jonathan Guillemot Imagine sitting in the chair of a venture capitalist: you have two candidates, one with an average idea with strong evidence that there is a need for the product and another with a very innovative project but who did not give too much thought into the evidence. It is likely that the candidate with strong evidence will get the funding. What could the innovative project candidate have done to more effectively make their case?
0